The stepwise synthesis and characterization of three new mixed-ligand organometallic tetranuclear platinum squares were achieved. All of the complexes were constituted by the conjunction of two (2,2′-bpy)Pt-terph-Pt(2,2′-bpy) (terph = p-terphenyl) fragments linked by a variety of N^N ligands (4,4′-bipyridine (4,4′-bpy), 1,4-di(pyridin-4-yl)benzene (dpbz), and 4,4′-di(pyridin-4-yl)-1,1′-biphenyl (dpbph)), which occupied the fourth coordination site of each metal center, giving rise to square-shaped molecules of the general formula [Pt2(2,2′-bpy)2(terph)(N^N)]2. Consequently, the tetranuclear complexes, {[Pt(2,2′-bpy)]4(μ-terph)2(μ-4,4′-bpy)2}{PF6}4 (7), {[Pt(2,2′-bpy)]4(μ-terph)2(μ-dpbz)2}{PF6}4 (8), and {[Pt(2,2′-bpy)]4(μ-terph)2(μ-dpbph)2}{PF6}4 (9) were constructed. The photophysical properties of these complexes were studied both in the solid state and in various solvents, revealing fluorosolvatochromism.
No takes yet. Share an insight, caveat, or question.
Garypidou et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: